Drug Shortage Report for RIVA-PYRIDOSTIGMINE
Report ID | 133116 |
Drug Identification Number | 02495643 |
Brand name | RIVA-PYRIDOSTIGMINE |
Common or Proper name | Riva-Pyridostigmine |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PYRIDOSTIGMINE BROMIDE |
Strength(s) | 60MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N07AA |
ATC description | PARASYMPATHOMIMETICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-03-15 |
Actual start date | |
Estimated end date | 2021-04-16 |
Actual end date | 2021-03-30 |
Shortage status | Resolved |
Updated date | 2021-03-31 |
Company comments | Product under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-03-31 | English | Compare |
v8 | 2021-03-30 | French | Compare |
v7 | 2021-03-30 | English | Compare |
v6 | 2021-03-16 | English | Compare |
v5 | 2021-03-02 | French | Compare |
v4 | 2021-03-02 | English | Compare |
v3 | 2021-03-02 | English | Compare |
v2 | 2021-02-02 | French | Compare |
v1 | 2021-02-02 | English | Compare |
Showing 1 to 9 of 9